The National Cancer Institute (NCI) is offering this grant to support investigator-initiated early phase clinical trials. This grant is for research projects focusing on cancer-targeted diagnostic and therapeutic interventions. The NCI’s Division of Cancer Treatment and Diagnosis (DCTD) seeks proposals for Phase 0, I, and II trials, aligning with their research mission. Applicants must ensure proposed studies meet the National Institutes of Health (NIH) definition of a clinical trial. Detailed clinical trial information is required. Importantly, this funding opportunity does not support Phase III clinical trials in any cancer research area. The aim is to advance novel treatments and diagnostic methods through rigorous early-stage investigation.
Opportunity ID: 329803
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-033 |
| Funding Opportunity Title: | National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 12, 2020 |
| Last Updated Date: | Nov 12, 2020 |
| Original Closing Date for Applications: | Jan 07, 2024 |
| Current Closing Date for Applications: | Jan 07, 2024 |
| Archive Date: | Feb 12, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education County governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Independent school districts Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of the National Cancer Institute’s (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Applicants are strongly encouraged to consult the NCI DCTD website at https://dctd.cancer.gov/ to learn more about the various program goals, research priorities, and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. Applications that propose phase III clinical trials in any area of cancer research are not sought by and will not be supported through this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-033.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 329803 Full Announcement-PAR-21-033 -> PAR-21-033-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00264069 | Dec 07, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269766 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277725 | Nov 01, 2022 | Jan 07, 2024 | View |
Package 1
Mandatory forms
329803 RR_SF424_2_0-2.0.pdf
329803 PHS398_CoverPageSupplement_5_0-5.0.pdf
329803 RR_OtherProjectInfo_1_4-1.4.pdf
329803 PerformanceSite_2_0-2.0.pdf
329803 RR_KeyPersonExpanded_2_0-2.0.pdf
329803 PHS398_ResearchPlan_4_0-4.0.pdf
329803 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
329803 RR_Budget_1_4-1.4.pdf
329803 RR_SubawardBudget30_1_4-1.4.pdf
329803 PHS398_ModularBudget_1_2-1.2.pdf
329803 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
329803 RR_SF424_5_0-5.0.pdf
329803 PHS398_CoverPageSupplement_5_0-5.0.pdf
329803 RR_OtherProjectInfo_1_4-1.4.pdf
329803 PerformanceSite_4_0-4.0.pdf
329803 RR_KeyPersonExpanded_4_0-4.0.pdf
329803 PHS398_ResearchPlan_4_0-4.0.pdf
329803 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
329803 RR_Budget_3_0-3.0.pdf
329803 RR_SubawardBudget30_3_0-3.0.pdf
329803 PHS398_ModularBudget_1_2-1.2.pdf
329803 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
329803 RR_SF424_5_0-5.0.pdf
329803 PHS398_CoverPageSupplement_5_0-5.0.pdf
329803 RR_OtherProjectInfo_1_4-1.4.pdf
329803 PerformanceSite_4_0-4.0.pdf
329803 RR_KeyPersonExpanded_4_0-4.0.pdf
329803 PHS398_ResearchPlan_5_0-5.0.pdf
329803 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
329803 RR_Budget_3_0-3.0.pdf
329803 RR_SubawardBudget30_3_0-3.0.pdf
329803 PHS398_ModularBudget_1_2-1.2.pdf
329803 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
